Danaher Corporation (DHR)
Bamco Inc. NY Decreases Stock Holdings in Danaher Corporation $DHR
Bamco Inc. NY lowered its stake in Danaher Corporation (NYSE: DHR) by 36.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 47,329 shares of the conglomerate's stock after selling 26,807 shares during the quarter. Bamco Inc. NY's holdings in Danaher were worth
Bank of Nova Scotia Sells 248,580 Shares of Danaher Corporation $DHR
Bank of Nova Scotia decreased its position in shares of Danaher Corporation (NYSE: DHR) by 54.0% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 211,365 shares of the conglomerate's stock after selling 248,580 shares during the
Banco Bilbao Vizcaya Argentaria S.A. Has $14.18 Million Stock Position in Danaher Corporation $DHR
Banco Bilbao Vizcaya Argentaria S.A. grew its stake in Danaher Corporation (NYSE: DHR) by 63.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 72,032 shares of the conglomerate's stock after buying an additional 27,834 shares during the quarter. Banco Bilbao Vizcaya Argentaria
Danaher Corporation $DHR Shares Purchased by Ameriprise Financial Inc.
Ameriprise Financial Inc. increased its holdings in shares of Danaher Corporation (NYSE: DHR) by 211.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,088,089 shares of the conglomerate's stock after buying an additional 1,418,243 shares during the quarter. Ameriprise Financial
Anchor Investment Management LLC Sells 4,317 Shares of Danaher Corporation $DHR
Anchor Investment Management LLC reduced its holdings in shares of Danaher Corporation (NYSE: DHR) by 48.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,614 shares of the conglomerate's stock after selling 4,317 shares during the period. Anchor Investment
Arrowstreet Capital Limited Partnership Boosts Stock Position in Danaher Corporation $DHR
Arrowstreet Capital Limited Partnership increased its stake in Danaher Corporation (NYSE: DHR) by 33.9% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,519,013 shares of the conglomerate's stock after purchasing an additional 891,210 shares during the quarter. Arrowstreet Capital Limited Partnership
Danaher Corporation (DHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Danaher Corporation (DHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Danaher's $9.9B Masimo Deal Marks One of 2026's Largest Medtech Buyouts
Danaher (NYSE: DHR) is acquiring Masimo (NASDAQ: MASI) for $9.9 billion in an all-cash deal that values the medical technology company at $180 per share.
Danaher to acquire Masimo in $9.9B all-cash deal
Danaher Corporation (NYSE:DHR) announced it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) in an all-cash transaction valued at approximately $9.9 billion, as the life sciences and diagnostics company looks to expand its patient monitoring capabilities. Under the terms of the agreement, Danaher will acquire all outstanding Masimo common shares for $180 per share in cash.
Danaher closes in on nearly $10 billion deal for Masimo, FT reports
US healthcare manufacturer Danaher is closing in a nearly $10 billion deal to acquire medical technology company Masimo , the Financial Times reported on Monday, citing people familiar with the matter.
Danaher Stock Plunge Does Not Represent A Good Entry Point
Danaher Stock Plunge Does Not Represent A Good Entry Point
Danaher Q4 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
DHR beats Q4 estimates as sales rise 4.5%, driven by strength across Life Sciences, Diagnostics and Biotech, and issued upbeat 2026 earnings guidance.
